Alkem Laboratories Limited (NSE: ALKEM)

Alkem Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	-	4,551	2,738	2,322	1,742	1,759
Short-Term Investments	-	36,710	7,339	9,424	14,123	1,163
Trading Asset Securities	-	1,436	1,355	1,385	1,671	1,681
Cash & Short-Term Investments	42,697	42,697	11,432	13,130	17,537	4,603
Cash Growth	273.50%	273.50%	-12.94%	-25.13%	281.00%	-29.64%
Accounts Receivable	-	22,855	21,442	18,880	16,072	16,494
Other Receivables	-	1,658	1,782	1,607	2,829	2,336
Receivables	-	24,603	23,292	20,689	19,088	19,110
Inventory	-	26,612	26,075	30,055	23,124	18,188
Prepaid Expenses	-	499.1	443.9	564.4	303.6	318.1
Other Current Assets	-	9,704	26,054	19,915	9,235	12,838
Total Current Assets	-	104,116	87,297	84,354	69,288	55,057
Property, Plant & Equipment	-	25,570	25,135	27,659	27,064	27,741
Long-Term Investments	-	4,051	5,249	8,803	1,586	1,119
Goodwill	-	4,167	4,132	4,031	3,954	3,985
Other Intangible Assets	-	575.8	793.9	721.9	844.4	984.1
Long-Term Deferred Tax Assets	-	15,148	13,025	13,093	11,079	9,326
Other Long-Term Assets	-	2,120	1,855	1,950	1,297	1,138
Total Assets	-	155,749	137,567	140,692	115,193	99,455
Accounts Payable	-	17,481	11,650	11,734	10,694	9,541
Accrued Expenses	-	8,506	9,248	7,941	6,443	5,237
Short-Term Debt	-	11,726	13,071	25,706	16,360	15,035
Current Portion of Long-Term Debt	-	13.4	0.3	1.2	368.3	381
Current Portion of Leases	-	151.8	192	216	215.5	218.2
Current Income Taxes Payable	-	549.9	234.4	163.2	189.3	381.7
Current Unearned Revenue	-	39.1	10.5	12.4	16.8	19.4
Other Current Liabilities	-	1,478	2,665	2,280	1,754	1,633
Total Current Liabilities	-	39,946	37,072	48,053	36,041	32,446
Long-Term Debt	-	400	-	93.8	279.3	675.9
Long-Term Leases	-	1,893	703.3	664.7	697.1	916.5
Long-Term Unearned Revenue	-	258.4	88	79.2	88.3	97.7
Other Long-Term Liabilities	-	4,178	3,652	1,775	1,311	1,048
Total Liabilities	-	48,605	43,217	52,219	39,613	36,366
Common Stock	-	239.1	239.1	239.1	239.1	239.1
Retained Earnings	-	102,970	90,392	85,811	73,540	61,037
Comprensive Income & Other	-	-88	-178.4	328.5	-11.8	330.2
Total Common Equity	103,121	103,121	90,453	86,379	73,767	61,607
Minority Interest	-	4,023	3,897	2,094	1,813	1,483
Shareholders' Equity	107,144	107,144	94,350	88,473	75,580	63,090
Total Liabilities & Equity	-	155,749	137,567	140,692	115,193	99,455
Total Debt	14,184	14,184	13,967	26,682	17,920	17,227
Net Cash (Debt)	28,513	28,513	-2,535	-13,552	-382.8	-12,624
Net Cash Per Share	238.48	238.47	-21.20	-113.34	-3.20	-105.58
Filing Date Shares Outstanding	119.55	119.57	119.57	119.57	119.57	119.57
Total Common Shares Outstanding	119.55	119.57	119.57	119.57	119.57	119.57
Working Capital	-	64,170	50,225	36,301	33,248	22,611
Book Value Per Share	862.46	862.46	756.52	722.44	616.96	515.26
Tangible Book Value	98,377	98,377	85,527	81,626	68,969	56,638
Tangible Book Value Per Share	822.79	822.79	715.32	682.69	576.83	473.70
Land	-	1,472	1,369	1,373	2,014	2,017
Buildings	-	10,226	8,786	9,672	8,807	8,635
Machinery	-	23,690	21,710	22,554	19,732	18,335
Construction In Progress	-	1,484	3,103	3,395	3,933	3,630

Source: S&P Capital IQ. Standard template. Financial Sources.